Immune Checkpoint Inhibitor Outcomes for Patients With Non-Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications. [electronic resource]
Producer: 20200601Description: 1927-1934 p. digitalISSN:- 1527-7755
- Adrenal Cortex Hormones -- administration & dosage
- Adult
- Aged
- Aged, 80 and over
- B7-H1 Antigen -- antagonists & inhibitors
- CTLA-4 Antigen -- antagonists & inhibitors
- Carcinoma, Non-Small-Cell Lung -- complications
- Disease Progression
- Disease-Free Survival
- Female
- Humans
- Immune System
- Immunotherapy -- methods
- Lung Neoplasms -- complications
- Male
- Middle Aged
- Neoplasm Metastasis
- Palliative Care -- methods
- Prednisone -- administration & dosage
- Proportional Hazards Models
- Pulmonary Disease, Chronic Obstructive -- complications
- Radiation Pneumonitis -- complications
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.